title: Fosfomycin for multidrug treatment of Klebsiella pneumoniae carbapenemase bacteremia.
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Juliana M
authors.initials: JM
authors.lastname: Kyle
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN, USA joanna.stollings@vanderbilt.edu.
authors.forename: Joanna L
authors.initials: JL
authors.lastname: Stollings
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Katie D
authors.initials: KD
authors.lastname: White
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Noto
authors.affiliation: Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Arthur P
authors.initials: AP
authors.lastname: Wheeler
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy*; D001426:Bacterial Proteins / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects* / Q000235:genetics; D004359:Drug Therapy, Combination; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000097:blood / Q000188:drug therapy*; D007711:Klebsiella pneumoniae / Q000201:enzymology / Q000235:genetics; D008297:Male; D001618:beta-Lactamases / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D005578:Fosfomycin; D001618:beta-Lactamases; C063912:carbapenemase